Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide + dexamethasone for relapsed or refractory multiple myeloma
ChiCTR-ONC-13004096Phase 2Recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Jul 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lenalidomide and dexamethasone in multiple myeloma (MM), sponsored by Shanghai Changzheng Hospital. Primary endpoint: Overall response rate. Started Jul 2012; status: recruiting.
02
Drugs
lenalidomidedexamethasone
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on ChiCTR-ONC-13004096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-13004096.